| Fiji | | |
Age-standardized prevalence of tobacco use among persons 15 years and olders (%) | 23.1% (2020) [64/164countries] | | |
|
| Fiji | | |
New HIV infections (per 1000 uninfected population) | 0.16 (2020) [54/130countries] | | | Tuberculosis incidence (per 100,000 population) | 66.0 (2021) [73/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.1 (2020) [132/194countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 37.7 (2019) [6/183countries] | | |
|
| Fiji | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 169.7 (2020) [84/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 2.4 (2020) [119/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 0.2 (2020) [179/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 65.1 (2020) [47/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 29.8 (2020) [30/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 9.5 (2020) [108/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 14.6 (2020) [34/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 1.1 (2020) [46/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 0.6 (2020) [173/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.6 (2020) [87/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 5.8 (2020) [74/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 2.9 (2020) [68/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 8.8 (2020) [39/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 6.5 (2020) [128/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 2.0 (2020) [149/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.0 (2020) [120/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [117/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 5.9 (2020) [104/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 2.6 (2020) [85/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [120/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 12.4 (2020) [6/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 3.5 (2020) [100/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 48.6 (2020) [68/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 3.7 (2020) [149/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 3.8 (2020) [47/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 7.7 (2020) [41/184countries] | | |
|
| Fiji | | |
Suicide, age-standardized (per 100 000 population) | 9.51 (2019) [78/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 13.08 (2019) [96/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 5.96 (2019) [48/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 15.37 (2019) [16/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 18.13 (2019) [25/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 12.48 (2019) [10/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 12.92 (2019) [42/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 18.33 (2019) [50/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 7.29 (2019) [25/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 10.45 (2019) [85/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 16.17 (2019) [83/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 4.40 (2019) [75/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 8.42 (2019) [121/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 12.68 (2019) [121/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 3.99 (2019) [113/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 11.47 (2019) [106/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 15.63 (2019) [117/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 7.38 (2019) [82/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 12.93 (2019) [106/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 18.72 (2019) [112/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 7.95 (2019) [91/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 16.93 (2019) [99/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 25.57 (2019) [109/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 11.08 (2019) [84/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 50.29 (2019) [66/183countries] | | |
|
|